Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

8 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Unnatural rigid scaffolds targeting the bacterial ribosome.
Katsoulis IA, Pyrkotis C, Papakyriakou A, Kythreoti G, Zografos AL, Mavridis I, Nahmias VR, Anastasopoulou P, Vourloumis D. Katsoulis IA, et al. Chembiochem. 2009 Aug 17;10(12):1969-72. doi: 10.1002/cbic.200900268. Chembiochem. 2009. PMID: 19585638 No abstract available.
Designed spiro-bicyclic analogues targeting the ribosomal decoding center.
Cottin T, Pyrkotis C, Stathakis CI, Mavridis I, Katsoulis IA, Anastasopoulou P, Kythreoti G, Zografos AL, Nahmias VR, Papakyriakou A, Vourloumis D. Cottin T, et al. Among authors: katsoulis ia. Chembiochem. 2011 Jan 3;12(1):71-87. doi: 10.1002/cbic.201000591. Chembiochem. 2011. PMID: 21154494
Rationally designed less toxic SPD-304 analogs and preliminary evaluation of their TNF inhibitory effects.
Alexiou P, Papakyriakou A, Ntougkos E, Papaneophytou CP, Liepouri F, Mettou A, Katsoulis I, Maranti A, Tsiliouka K, Strongilos A, Chaitidou S, Douni E, Kontopidis G, Kollias G, Couladouros E, Eliopoulos E. Alexiou P, et al. Arch Pharm (Weinheim). 2014 Nov;347(11):798-805. doi: 10.1002/ardp.201400198. Epub 2014 Aug 27. Arch Pharm (Weinheim). 2014. PMID: 25160057
Dutasteride plus tamsulosin fixed-dose combination first-line therapy versus tamsulosin monotherapy in the treatment of benign prostatic hyperplasia: a budget impact analysis in the Greek healthcare setting.
Geitona M, Karabela P, Katsoulis IA, Kousoulakou H, Lyberopoulou E, Bitros E, Xaplanteris L, Papanicolaou S. Geitona M, et al. Among authors: katsoulis ia. BMC Urol. 2014 Sep 26;14:78. doi: 10.1186/1471-2490-14-78. BMC Urol. 2014. PMID: 25255740 Free PMC article.